There were 1,880 press releases posted in the last 24 hours and 358,835 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Oncternal Therapeutics Receives IND Clearance for ONCT-808, its autologous CAR T Product Candidate Targeting ROR1 for the Treatment of Aggressive B Cell Lymphoma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image